Check out the companies making headlines before the bell.
Intel's shares surged 6.7% after reporting better-than-expected second-quarter results and a return to profitability after two consecutive losing periods. The company's third-quarter forecast also exceeded analyst expectations.
Roku's stock rallied nearly 10% as the streaming company reported a narrower-than-expected loss for the second quarter, beating revenue estimates.
Biogen shares dipped slightly as the biotechnology company announced its acquisition of Reata Pharmaceuticals in a cash deal valued at about $7.3 billion. Shares of Reata surged over 51% on the news.
Procter & Gamble saw its shares rise over 1% in premarket trading following the release of quarterly earnings and revenue that beat analysts' expectations. However, the company's fiscal 2024 sales outlook fell short of Wall Street's estimates.
Exxon Mobil's shares declined slightly after posting mixed second-quarter results, with earnings falling short of analysts' expectations, but revenue surpassing estimates.
Chevron's stock lost nearly 1% despite beating expectations on both top and bottom lines for the second quarter, attributed to a drop in oil prices.
First Solar's shares soared 12% after reporting better-than-expected earnings and revenue for the second quarter. The solar company also announced plans to invest up to $1.1 billion in building a fifth manufacturing facility in the U.S.
Enphase Energy's stock dropped more than 15% after reporting second-quarter revenue that fell short of analyst estimates. The company also faced downgrades from Deutsche Bank, Wells Fargo, and Roth MKM.
Sweetgreen's shares slid over 13% as the salad chain reported weak sales that missed Wall Street expectations in the second quarter, along with a net loss.
Ford Motor reported strong quarterly earnings, beating Wall Street expectations, and raised its full-year guidance. However, the automaker noted slower adoption of electric vehicles than previously forecasted and expected losses of $4.5 billion in the EV business this year.
Juniper Networks' shares fell 8% after the company provided a third-quarter guidance below expectations, impacting earnings per share and revenue.
AstraZeneca's U.S.-listed shares rose more than 5% as the drugmaker reported second-quarter earnings and revenue that exceeded analysts' expectations. AstraZeneca also announced its acquisition of a portfolio of preclinical rare disease gene therapies from Pfizer.
Xpeng, a Chinese electric-vehicle stock, jumped over 6% after Jefferies upgraded its shares to a buy from a hold, citing the company's joint development plan with Volkswagen.
New York Community Bancorp's stock rose approximately 2% following JPMorgan's upgrade of the bank to an overweight rating from neutral, praising its position as a "massive market share taker."
Mondelez International added 2.7% on strong second-quarter results, with earnings and revenue surpassing estimates.
As a leading independent research provider, TradeAlgo keeps you connected from anywhere.